Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Inositol prevents hair loss and improves health in rats.

Balding people may have higher heart disease risk.

A new microneedle patch effectively and safely treats alopecia areata.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Sebaceous gland maturity and size differ between psoriatic alopecia and alopecia areata.

Micronutrient imbalances like zinc, selenium, copper, and manganese can cause hair loss.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Correcting trace element imbalances may help reduce alopecia areata symptoms.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

SQSTM1 gene issues may increase the risk of alopecia areata.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The system can have a stable solution under certain conditions, helping understand hair loss in Alopecia Areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

A rare skin cancer caused hair loss and spread, needing multiple treatments.